Oct 2026· International Journal of Health Engineering and Technology· 0 citations· 16 references
TL;DR
Thrombolysis plays a role in restoring cerebral blood flow through thrombus lysis, one of the main therapies that provides optimal benefits when administered as early as possible to patients who meet the appropriate criteria.
Abstract
Stroke is one of the leading causes of morbidity and mortality worldwide, with ischemic stroke being the most common type. Ischemic stroke occurs due to obstruction of blood flow to brain tissue, resulting in ischemia, hypoxia, and potentially irreversible brain tissue damage if not treated promptly and appropriately. In the acute phase, the primary principle of management is to restore blood flow to hypoperfused areas of the brain as quickly as possible in order to preserve viable brain tissue, particularly the ischemic penumbra. One of the main reperfusion modalities is thrombolytic therapy, which aims to lyse intravascular thrombi and restore cerebral blood flow. Although thrombolytic therapy provides benefits in improving functional outcomes, it carries a risk of complications, particularly intracranial hemorrhage; therefore, appropriate patient selection, imaging evaluation, and monitoring are required. This final assignment uses a literature review method by examining various sources that discuss thrombolytic therapy in patients with acute ischemic stroke. The literature reviewed covers ischemic stroke, the mechanism of action of thrombolytic agents, methods of administration, inclusion and exclusion criteria, intravenous and intra-arterial thrombolysis, mechanical thrombectomy, types of thrombolytic agents, imaging prior to thrombolysis, as well as complications and therapeutic monitoring. Relevant literature was subsequently reviewed and descriptively organized to provide a comprehensive overview of the role of thrombolysis in the management of acute ischemic stroke. Based on the literature review, thrombolysis plays a role in restoring cerebral blood flow through thrombus lysis. Intravenous alteplase is one of the main therapies that provides optimal benefits when administered as early as possible to patients who meet the appropriate criteria. Patient selection, brain imaging, and monitoring are necessary to reduce the risk of complications, particularly intracranial hemorrhage. Thrombolysis is an important reperfusion therapy for acute ischemic stroke. Prompt and appropriate administration in patients who meet the criteria can improve functional outcomes, while taking into consideration the risk of bleeding and the need for close monitoring.
Background: Ischemic stroke is a leading cause of morbidity and mortality worldwide, with intravenous thrombolysis using alteplase representing the main reperfusion therapy. However, hemorrhagic transformation (HT) after thrombolysis is a serious complication associated with disruption of the blood–brain barrier, micro...
Letícia Fernandes de Freitas, Miguel Ramos de Oliveira, Isaac Coelho de Sousa et al.· ANPAbstract_CBN26· 0 citations
BACKGROUND
Restoring blood flow to ischemic tissue is the cornerstone of acute stroke therapy and is usually beneficial. However, when reperfusion is achieved for severely injured tissue, it is often futile and may occasionally cause harm. We aim to determine the prevalence and variables associated with clinical no imp...
U. Pensato, T. Field, B. van Adel et al.· Stroke· 0 citations
Acute ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide. Although reperfusion therapies, including thrombolysis and mechanical thrombectomy, have demonstrated efficacy, a substantial proportion of patients fail to achieve the expected functional recovery, highlighting the...
Yu.G. Serhiienko, N. Nekrasova, Yurii O. Kotlyarevskyi et al.· Ukrainian Neurosurgical Jour...· 0 citations
Background: Acute posterior circulation strokes (POCS) account for approximately 20% of ischemic strokes, are associated with higher mortality, and often present with atypical clinical features, leading to loss of the traditional therapeutic window for reperfusion with alteplase (rtPA) in the acute phase. Furthermore,...
Iago Blanco Bacchiega, V. Vasconcelos, José Elias Makaron et al.· ANPAbstract_CBN26· 0 citations
BACKGROUND
Endovascular thrombectomy is an established treatment for acute ischemic stroke. Whether the benefit extends to patients with salvageable brain tissue in the infarct who present more than 24 hours after symptom onset or the time when they were last known to be well is uncertain.
METHODS
We conducted an ope...
Peng-Fei Yang, Hong-Jian Shen, Ting-Yu Yi et al.· New England Journal of Medic...· 0 citations
Background: Acute ischemic stroke (AIS) is a leading cause of disability and mortality worldwide. Intravenous thrombolysis (IVT) improves functional outcomes when administered within the recommended time window; however, treatment response varies among patients. Admission hyperglycemia is common in acute stroke and may...
L. T. A. Carretta, L. Di Cosmo, Rafael Torres Fonseca dos Santos et al.· ANPAbstract_CBN26· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.